Stati Uniti - Ingliż - NLM (National Library of Medicine)

sanum kehlbeck gmbh & co. kg - aspergillus niger var. niger (unii: 9ioa40ang6) (aspergillus niger var. niger - unii:9ioa40ang6) - aspergillus niger var. niger 3 [hp_x] - for temporary relief of external itching and soreness in the urogenital region.

Stati Uniti - Ingliż - NLM (National Library of Medicine)

sanum kehlbeck gmbh & co. kg - aspergillus niger var. niger (unii: 9ioa40ang6) (aspergillus niger var. niger - unii:9ioa40ang6) - aspergillus niger var. niger 4 [hp_x] - for temporary relief of external itching and soreness in the urogenital region.

Stati Uniti - Ingliż - NLM (National Library of Medicine)

sanum kehlbeck gmbh & co. kg - aspergillus flavus var. oryzae (unii: q6z8uk5r3g) (aspergillus flavus var. oryzae - unii:q6z8uk5r3g) - aspergillus flavus var. oryzae 6 [hp_x] in 10 ml - for discomfort related to cold feet and hands.

Ingilterra - Ingliż - MHRA (Medicines & Healthcare Products Regulatory Agency)

allergopharma - aspergillus fumigatus allergen extract - solution for skin-prick test

Stati Uniti - Ingliż - NLM (National Library of Medicine)

newton laboratories, inc. - aspergillus niger var. niger (unii: 9ioa40ang6) (aspergillus niger var. niger - unii:9ioa40ang6), cladosporium herbarum (unii: o64jf11198) (cladosporium herbarum - unii:o64jf11198), candida albicans (unii: 4d7g21hdbc) (candida albicans - unii:4d7g21hdbc), thyroid, unspecified (unii: 0b4fdl9i6p) (thyroid, unspecified - unii:0b4fdl9i6p), ustilago maydis (unii: 4k7z7k7swg) (ustilago maydis - unii:4k7z7k7swg), aconitum napellus (unii: u0nq8555jd) (aconitum napellus - unii:u0nq8555jd), antimony potassium tartrat - aspergillus niger var. niger 15 [hp_x] in 1 g - formulated for symptoms such as valley fever, gulf war syndrome, environmental sensitivity and other related conditions. formulated for symptoms associated with valley fever, gulf war syndrome, environmental sensitivity and other related conditions.

Stati Uniti - Ingliż - NLM (National Library of Medicine)

sanpharma gmbh - aspergillus niger var. niger (unii: 9ioa40ang6) (aspergillus niger var. niger - unii:9ioa40ang6) - aspergillus niger var. niger 3 [hp_x] - for lymphatic stagnation.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - voriconazole, quantity: 40 mg/ml - suspension, powder for - excipient ingredients: titanium dioxide; sodium benzoate; citric acid; colloidal anhydrous silica; sodium citrate dihydrate; sucrose; xanthan gum; flavour - vfend is indicated for treatment of the following fungal infections: invasive aspergillosis. serious candida infections (including c. krusei), including oesophageal and systemic candida infections (hepatosplenic candidiasis, disseminated candidiasis, candidaemia). serious fungal infections caused by scedosporium spp and fusarium spp. other serious fungal infections, in patients intolerant of, or refractory to, other therapy. *prophylaxis in patients who are at high risk of developing invasive fungal infections. the indication is based on studies including patients undergoing haematopoietic stem cell transplantation.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - voriconazole, quantity: 200 mg - injection, powder for - excipient ingredients: sulfobutyl betadex sodium - vfend is indicated for treatment of the following fungal infections: invasive aspergillosis. serious candida infections (including c. krusei), including oesophageal and systemic candida infections (hepatosplenic candidiasis, disseminated candidiasis, candidaemia). serious fungal infections caused by scedosporium spp and fusarium spp. other serious fungal infections, in patients intolerant of, or refractory to, other therapy. *prophylaxis in patients who are at high risk of developing invasive fungal infections. the indication is based on studies including patients undergoing haematopoietic stem cell transplantation.

Stati Uniti - Ingliż - NLM (National Library of Medicine)

nelco laboratories, inc. - aspergillus fumigatus (unii: x88df51t48) (aspergillus fumigatus - unii:x88df51t48) - allergenic extracts are indicated for use in diagnostic testing and as part of a treatment regime for allergic disease, as established by allergy history and skin test reactivity. allergenic extracts are indicated for the treatment of allergen specific allergic disease for use as hyposensitization or immunotherapy when avoidance of specific allergens can not be attained. the use of allergenic extracts for therapeutic purpose has been established by well-controlled clinical studies. allergenic extracts may be used as adjunctive therapy along with pharmacotherapy which includes antihistamines, corticosteroids, and cromoglycate, and avoidance measures. allergenic extracts for therapeutic use should be given using only the allergen selection to which the patient is allergic, has a history of exposure and are likely to be exposed to again. allergenic extracts should not be used if the patient has asthma, cardiovascular disease, emphysema, diabetes, bleeding diathesis or pregnancy, unless a specific diagnosis of t

Stati Uniti - Ingliż - NLM (National Library of Medicine)

nelco laboratories, inc. - aspergillus fumigatus (unii: x88df51t48) (aspergillus fumigatus - unii:x88df51t48) - allergenic extracts are indicated for use in diagnostic testing and as part of a treatment regime for allergic disease, as established by allergy history and skin test reactivity. allergenic extracts are indicated for the treatment of allergen specific allergic disease for use as hyposensitization or immunotherapy when avoidance of specific allergens can not be attained. the use of allergenic extracts for therapeutic purpose has been established by well-controlled clinical studies. allergenic extracts may be used as adjunctive therapy along with pharmacotherapy which includes antihistamines, corticosteroids, and cromoglycate, and avoidance measures. allergenic extracts for therapeutic use should be given using only the allergen selection to which the patient is allergic, has a history of exposure and are likely to be exposed to again. allergenic extracts should not be used if the patient has asthma, cardiovascular disease, emphysema, diabetes, bleeding diathesis or pregnancy, unless a specific diagnosis of t